BISU Bio-Solutions Corp.

[chuck44l]

BISU off to a great start this morning congrats to all who got in on our alert in the chat room yesterday + 132% For more on BISU and many other stocks to watch join us in the penny stock chat room at http://www.stockplaysonline.com/visichat/

Be sure to check back often as we have more BISU info to post to the forum coming very soon.

[chuck44l]

BISU .084 + 236% weeeeeeeeeeeeeeeeee If you are in the chat room you are missing the boat!!!!
Don't get greedy and forget to take profits.
For more on BISU and many other stocks to watch join us in the penny stock chat room at http://www.stockplaysonline.com/visichat/

[Jav992]

Bio-Solutions Corp Fully Pursuing $15 Billion Type II and Pre-Diabetic Marketplace


MONTREAL--(Marketwire -05/03/12)- (BISU.PK - News) (BISU.PK - News) Bio-Solutions Corp is pleased to announce a new era. The company will be changing its core business away from GREENEX™ and NutraAnimal™, in order to focus entirely on Type2 Defense™. Type2 Defense™, acquired by the company September of last year, is an Anti-Oxidant rich glucose control dietary supplement powder. This proprietary formula is packaged with 30 packets to a box. The product powder drink mix delivery system has been developed to support healthy glucose levels for type 2 diabetics and pre-diabetics. From a "Target Market" perspective, management believes this to be a very lucrative market place that has a built in clientele here domestically in North America to drive sales and revenues.

There is an Estimated 100 Plus Million Americans at risk of diabetes in the following order:

Data from the 2011 National Diabetes Fact Sheet (released Jan. 26, 2011)
Total prevalence of diabetes
Total: 25.8 million children and adults in the United States -- 8.3% of the population -- have diabetes.
Diagnosed:18.8 million people
Undiagnosed: 7.0 million people
Prediabetes:79 million people*

New Cases:1.9 million new cases of diabetes are diagnosed in people aged 20 years and older in 2010.

* In contrast to the 2007 National Diabetes Fact Sheet, which used fasting glucose data to estimate undiagnosed diabetes and prediabetes, the 2011 National Diabetes Fact Sheet uses both fasting glucose and A1C levels to derive estimates for undiagnosed diabetes and prediabetes. These tests were chosen because they are most frequently used in clinical practice.

Given the two types of Diabetes (Type 1 and Type 2), Type2 Defense™ will obviously cater to Types 2 patients, which are 90-95%, of all diabetics. Type2 Defense™ will help maintain healthy blood glucose levels to combat complications of Diabetes which include:

1) Heart disease and stroke
2) High blood pressure


•In 2005-2008, of adults aged 20 years or older with self-reported diabetes, 67% had blood pressure greater than or equal to 140/90 mmHg or used prescription medications for hypertension.


3) Kidney disease


•Diabetes is the leading cause of kidney failure, accounting for 44% of new cases in 2008.
•In 2008, 48,374 people with diabetes began treatment for end-stage kidney disease in the United States.
•In 2008, a total of 202,290 people with end-stage kidney disease due to diabetes were living on chronic dialysis or with a kidney transplant in the United States.


4) Nervous system disease (Neuropathy)


•About 60% to 70% of people with diabetes have mild to severe forms of nervous system damage.


Financial operations will be managed in San Antonio with the company's controller, Rick Basse. Research and development is managed by ex Nestles' nutritional food scientist Sekhar Mallangi. Product fulfillment will be handled by Lou Bellino, one of Americas top web product fulfillment operators, marketing will be driven by the talented San Antonio based marketing firm BOSS Creative for the company's website development, (SEO) search engine optimization management, video product description and newsletters.

"We will be announcing Type2 Defense™ first production run very soon. We are excited about our new product, which will be sold and marketed primarily on the internet, further company developments, forthcoming," stated EVP Bill Gallagher.

According to Dailyfinance.com. (1/27/11 Big Pharma Article): "In 2009, the U.S. diabetes market grew 17% from 2008, reaching $14.9 billion, according to data from health care information company IMS Health. Worldwide, the market generated sales of over $25 Billion, according to independent business information provider Vision again. By 2019, Morningstar projects the worldwide diabetes market, excluding insulin, will grow to over $55 billion.

We believe that there is a growing market place that lacks adequate healthy tools to maintain healthy blood glucose levels. Type2 Defense™ is a powder blend of natural ingredients that has been developed to help support healthy blood glucose levels. The Type2 Defense™ powder blend is a flavorful supplement when mixed with water becomes an effective vehicle that encourages sustainable healthy habits. A convenient and all natural pure health beverage containing green tea blended with cinnamon and blueberry flavors and the Type2 Defense™ proprietary blend. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants.

[Jav992]

Bio-Solutions to Move Corporate Headquarters From Montreal, Canada to San Antonio, Texas


SAN ANTONIO, TX--(Marketwire -06/19/12)- As Bio-Solutions Corp. (BISU) launches Type2 Defense™, a state-of-the-art functional beverage for the management of Type 2 diabetes™,* President and CEO Bill Gallagher announces that the company will be operating out of San Antonio, Texas -- a move that places Bio-Solutions at the geographic hub of cutting-edge research in the fight against diabetes.

Bio-Solutions Corporation has seen many changes lately under Bill Gallagher, who has assumed responsibility in the wake of the resignation of former chief executive Gilles Chaumillion. Under Gallagher's new leadership Bio-Solutions announces today that the company will move its corporate headquarters San Antonio, Texas. The relocation from Montreal to San Antonio comes on the heels of Gallagher's appointment of Dr. Chandrasekhara Mallangi as head of research and development for a new functional beverage for glucose maintenance in diabetics. When asked about the move, Gallagher replied:

"Texas has always been the logical choice... We at Bio-Solutions feel that Type2 Defense™ can both improve the every-day health of those living with Type 2 diabetes and help to put a dent in the overall epidemic by serving the pre-diabetic population. When local interest crystallized into funding and support out of San Antonio, the decision to move became more than a business decision. It became a step forward in our mission to fight diabetes."

Texas and Diabetes -- the Epicenter of an Epidemic

As of 2010 25.8 million Americans -- 8.3% of the total United States population -- had been or could expect to be diagnosed with diabetes. The percentage of Texans affected by the disease is disproportionately high, with 9.3% of the state's population currently diagnosed. These numbers make diabetes the 7th most deadly disease in the nation -- and the 6th leading cause of death in Texas.(i) San Antonio is home to the Texas Diabetes Institute (TDI) -- the nation's largest, most comprehensive center for the research and treatment of diabetes.

Bio-Solutions' decision to move to San Antonio is based on support that goes beyond the proximity to research and development resources and consumer demand. The company -- which will be offering their innovative Type2 Defense™ through an internet-based subscription service -- has recently chosen San Antonio's Boss™ Creative Web Design to head up marketing technology. According to NSIDE Business, Boss Creative is "rapidly becoming one of the most innovative design companies in town." The trade magazine notes that "Boss Creative's youthful exuberance and knowledge of the industry shine through every project, reflecting a commitment to good design and the success of their clients."(ii) Boss Creative's approach to business and record of excellence match Bio-Solutions' progress as a successful business venture with a positive mission statement.

Bill Gallagher -- Getting Down to Business in the Fight against Diabetes

Bill Gallagher, President and CEO of Bio-Solutions Corporation, brings his professional history of successful enterprise to the table as Type2 Defense moves from production to distribution. This particular campaign joins Gallagher's lifelong mission to use good business to fuel change with his particular stake in the fight against diabetes -- a disease that has touched his family, providing the personal motivation that drives his venture toward success.

University of Texas alumnus Bill Gallagher is the founder and President of JagCapital, Inc., a merchant bank headquartered in San Antonio, Texas since September 1992. Mr. Gallagher's leadership at Bio-Solutions is informed by over 40 years of retail food experience. This experience rests on the strong foundation of Gallagher's long and colorful history of achievement in retail production, investment, and large-scale development projects. Mr. Gallagher's early success came in 1968 with his founding of Sunny's Stores and continued in 1989 with the opening of an international BBQ restaurant chain and the vending of its condiments -- and the eventual acquisition of Chris&Pitts BBQ Sauce, the top-selling BBQ sauce on the West Coast.

Gallagher's desire to use his personal success to better the world around him began in 1973, when he acquired Historic Gruene Texas and devoted himself to restoring and developing Gruene, Texas -- most of which had been uninhabited since 1925. Gallagher spearheaded this project for over a decade, invigorating the land and founding the Guadalupe Valley Winery Corporation -- a successful business that has helped to bring prosperity to the region.

Bio-Solutions' move to San Antonio lays the final stone to pave the way for the release of Type2 Defense, which hits the market in just a few weeks. The resources and support available in San Antonio and Bill Gallagher's personal and professional contributions have Bio-Solutions primed for success -- in business and, ultimately, in the fight against diabetes.

[Jav992]

Form 8-K for BIO-SOLUTIONS CORP.

26-Jun-2012

Change in Directors or Principal Officers



Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.
On June 20, 2012 Gilles Chaumillon tendered his resignation as an officer and director of the Company. Concurrent with his resignation, Mr. Gallagher, our current chief financial officer and a corporate director assumed the role as the Company's chief executive officer.

Mr. Chaumillon tendered his resignation for personal reasons and there was no disagreement between Mr. Chaumillon and the Company regarding its business operations or financial reporting.

A copy of this Form 8-k has been provided to Mr. Chaumillon

[Jav992]

Bio-Solutions Corp Begins Production of the Type2 Defense™. Pursuing $25 Billion plus Type II and Pre-Diabetic Marketplace

SAN ANTONIO, July 30, 2012 /PRNewswire/ -- (BISU) (BISU) Bio-Solutions Corp is pleased to announce that the company has started production of the recently acquired Type2 Defense™. Type2 Defense™ is an Antioxidant and glucose control dietary supplement powder. This proprietary formula is packaged with 30 packets to a box. The product powder drink mix delivery system has been developed to support healthy glucose levels for type 2 diabetics and pre-diabetics. From a "Target Market" perspective, management believes this to be a very lucrative market place that has a built in clientele here domestically in North America to drive sales and revenues. Type2 Defense™ has been scheduled for Market entry by September 2012. "We will be completing the first production run of Type2 Defense™ very soon. We are excited about our new product, which will be sold and marketed primarily on the internet, further company developments, forthcoming," stated newly appointed CEO Bill Gallagher.

There is an Estimated 100 plus Million Americans at risk of diabetes in the following order: Data from the 2011 National Diabetes Fact Sheet (released Jan. 26, 2011) Total prevalence of diabetes Total: 25.8 million children and adults in the United States -- 8.3% of the population -- have diabetes. Diagnosed: 18.8 million people Undiagnosed: 7.0 million people Pre-diabetes: 79 million people

New Cases: 1.9 million new cases of diabetes are diagnosed in people aged 20 years and older in 2010.

In contrast to the 2007 National Diabetes Fact Sheet, which used fasting glucose data to estimate undiagnosed diabetes and pre-diabetes, the 2011 National Diabetes Fact Sheet uses both fasting glucose and A1C levels to derive estimates for undiagnosed diabetes and pre-diabetes. These tests were chosen because they are most frequently used in clinical practice.

Given the two types of Diabetes (Type 1 and Type 2), Type2 Defense(TM) will obviously cater to Type 2 patients, which are 90-95%, of all diabetics. Type2 Defense(TM) will help maintain healthy blood glucose levels to combat complications of Diabetes which include: high blood
pressure

Operations will be managed in San Antonio. Research and development is managed by Ex Nestles SA nutritional food chief scientist Sekhar Mallangi. Product fulfillment will be handled by Lou Bellino, one of Americas top web product fulfillment operators, marketing will be driven by the talented San Antonio based marketing firm BOSS Creative for the company's new upcoming website development. Search engine optimization (SEO) management, video product description and newsletters.

According to Dailyfinance.com (1/27/11 Big Pharma Article), "In 2009, the U.S. diabetes market grew 17% from 2008, reaching $14.9 billion, according to data from health care information company IMS Health. Worldwide, the market generated sales of over $25 Billion, according to independent business information provider Vision again. By 2019, Morningstar projects the worldwide diabetes market, excluding insulin, will grow to over $55 billion."

We believe that there is a growing market place that lacks adequate healthy tools to maintain healthy blood glucose levels. Type2 Defense(TM) is a powder blend of natural ingredients that has been developed to help support healthy blood glucose levels. The Type2 Defense(TM) powder blend is a flavorful supplement when mixed with water becomes an effective vehicle that encourages sustainable healthy habits. A convenient and all natural pure health beverage containing green tea blended with cinnamon and blueberry flavors and the Type2 Defense(TM) proprietary blend. The Product's goal is to provide a safe and natural supplement that will assist in the stabilization of healthy glucose levels along with providing strong antioxidants.

[Jav992]

Highly Regarded Naturopath to Join Bio-Solutions Corp

SAN ANTONIO, Aug. 7, 2012 /PRNewswire/ -- Bio-Solutions Corp (BISU) (BISU) is pleased to announce the addition of Ms. Dana Kraft as a team member. Ms. Kraft is a UK-trained Naturopath, specialist in Nutritional Therapy, Herbal Medicine and Flower Essence Therapy. Upon completing her Masters dissertation in Media and Alternative Medicine at Goldsmiths College, University of London in 2005, Ms. Kraft realized that her real passion lay in natural medicine. Dana earned her diplomas at the prestigious College of Naturopathic Medicine (CNM) in London, graduating with qualifications in Nutritional Therapy, Herbal Medicine and Naturopathy. Dana also holds a BA in Communications from Tulane University and is co-founder and former Vice President of the UK's Naturopathic Nutrition Association (NMA).

Philosophy and Approach

The European style of naturopathy is an 'eclectic' approach to healing. Various tools and perspectives are incorporated in order to help set each individual on the right healing path. Herbal remedies, nutrition advice, flower essences, lifestyle changes and more will be recommended to clients as deemed appropriate for the individual. Dana often uses Traditional Chinese Medicine and/or Ayurvedic theory and diagnostic techniques (tongue and pulse analysis, face reading, etc.) as well as the use of Iridology, the study of the iris of the eye, to ascertain constitutional weakness and confirm suspected areas of disease in the body.

All of Dana's work is guided by the fundamental principles of naturopathy:
•The WHOLE person is treated – physically, mentally, emotionally and spiritually.
•The PERSON is treated, not the disease, and each individual is unique and responds in a different way to different remedies.
•The root (underlying) cause of dysfunction is identified and treated, not the branches (symptoms).
•Vis Medicatrix Naturae – The healing power of nature. There is 'vital force' or 'life force' which given the right conditions, will self-heal or self-correct.
•Health is much greater than just 'absence of infirmity' – it should be abundant vitality.
•Prevention is preferable to cure.

Bio-Solutions Corp would like to welcome Ms. Kraft to our organization and look forward to working with her in the development of future products/ brands.

Bio-Solutions Corp, Owns and Markets Type2 Defense(TM) (the "Product" or the "Supplement") is a glucose control dietary supplement powder formulated to support healthy glucose levels in addition to maintaining healthy blood pressure. Packaged with 30 packets to a box, the product powder drink mix delivery system has been developed to help support healthy glucose levels for type 2 diabetics and pre-diabetics. The product is also effective in controlling hypertension and has strong antioxidant powers.

[Jav992]

Bio-Solutions Corp. Shareholder Update
Entering $25 Billion Plus Diabetes Marketplace


SAN ANTONIO, Aug. 10, 2012 /PRNewswire/ -- Bio-Solutions Corp, (BISU) (BISU)is pleased to provide a shareholder update on recent news, events and the state of the company as a whole.

Since the acquisition Type2 Defense™ , (T2), in Sept of 2011, the company has engaged in running a test trail in an American suburban community, (composed of 1500 individuals), of the T2 product. The purpose of this test trail is to gauge the response and feedback from a segment of the population, towards the Type2 Defense™ product.

Type2 Defense™ (the "Product" or the "Supplement") is a glucose control dietary supplement powder formulated to help support healthy glucose levels, in addition to maintaining healthy blood pressure. Packaged with 30 packets to a box, the product powder drink mix delivery system has been developed to support healthy glucose levels for Type II Diabetics and Pre-diabetics. The product is also effective in controlling hypertension and has strong antioxidant powers.

Type II Diabetes and Pre-diabetics, account for over 90% of all diabetic cases. The product is delivered in 10 gram plastic packets (i.e. Emergent- C). The targeted market is health conscious individuals that have been diagnosed as Type II Diabetics or individuals who are concerned with Pre-diabetic symptoms.

According the Nation Diabetes Foundation: Type II Diabetes is the most common form of diabetes. Over 133 Million Americans have been diagnosed with Type II Diabetes, and many more are unaware they are at high risk. Some groups have a higher risk for developing Type II Diabetes than others. Increasing at about Two Million new American patients per year.

Since September 2011 there have been several management changes, at Bio-Solutions Corp. Prior management and directors have been replaced, with current CEO/CFO Mr. Bill Gallagher. Along with an impressive track record for brand, product building and sales, Mr. Gallagher brings his Forty plus years of sales experience and relationships to aid in the creation of the T2 brand. Mr. Gallagher has managed to recruit the expertise of Dr. Sekhar Mallangi, a Former Nestle SA Chief Scientist and the creator of Type2 Defense™. Ms. Dana Kraft, a well-recognized UK Naturopath. Mr. Gallagher's next mission is to recruit a soon to be Type2 Defense™ celebrity spokesperson, who will be endorsing the T2 Brand.

Bio-Solution Corp is a NV Corp, with Headquarters recently relocated to San Antonio Texas. Operations will be managed in San Antonio. Research and Development is managed by Dr. Mallangi. Product fulfillment will be handled by Lou Bellino, one of America's top web product fulfillment operators, marketing will be driven by the talented San Antonio based marketing firm BOSS Creative for the company's new upcoming website development. Search engine optimization (SEO) management, video product description and newsletters.

"Since the addition of both Type2 Defense™ and me, the company has never been in a better position to move forward. Production is occurring and the first product run of Type2 Defense™ is expected September 2012," stated CEO Bill Gallagher.

Bio-Solutions Corp. (BISU.QB) (BISU.PK)
Shares Outstanding: 67,190,397
Float: 15,000,000
Shares Authorized: 90,000,000

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions actual results to differ materially from those in the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.

Bio-Solutions Corp.
(210)268-9490

[Jav992]

Bio-Solutions Corp. Files Quarterly 10Q and Cleans up the Balance Sheet


SAN ANTONIO, Aug. 14, 2012 /PRNewswire/ -- Bio-Solutions Corp, (BISU) (BISU) is pleased to inform shareholders of the company's recent Quarterly filing. This most recent filing brings the company, ahead of their scheduled filing date.

Since the acquisition Type2 Defense™, (T2), in Sept of 2011, the company has actively been cleaning up the shape of the company and getting the company in the best position for the Launch of the T2 product. "The transition from moving headquarters and changing the product, has had its challenges, however everything is on schedule," stated CEO/ CFO Bill Gallagher.

Since the acquisition Type2 Defense™ , (T2), in Sept of 2011, the company has engaged in running a test trail in an American suburban community, (composed of 1500 individuals), of the T2 product. The purpose of this test trail is to gauge the response and feedback from a segment of the population, towards the Type2 Defense™ product.

Type2 Defense™ (the "Product" or the "Supplement") is a glucose control dietary supplement powder formulated to help support healthy glucose levels, in addition to maintaining healthy blood pressure. Packaged with 30 packets to a box, the product powder drink mix delivery system has been developed to support healthy glucose levels for Type II Diabetics and Pre-diabetics. The product is also effective in controlling hypertension and has strong antioxidant powers.

Type II Diabetes and Pre-diabetics, account for over 90% of all diabetic cases. The product is delivered in 10 gram plastic packets (i.e. Emergent- C). The targeted market is health conscious individuals that have been diagnosed as Type II Diabetics or individuals who are concerned with Pre-diabetic symptoms.

According the Nation Diabetes Foundation: Type II Diabetes is the most common form of diabetes. Over 133 Million Americans have been diagnosed with Type II Diabetes, and many more are unaware they are at high risk. Some groups have a higher risk for developing Type II Diabetes than others. Increasing at about Two Million new American patients per year.

Since September 2011 there have been several management changes, at Bio-Solutions Corp. Prior management and directors have been replaced, with current CEO/CFO Mr. Bill Gallagher. Along with an impressive track record for brand, product building and sales, Mr. Gallagher brings his Forty plus years of sales experience and relationships to aid in the creation of the T2 brand. Mr. Gallagher has managed to recruit the expertise of Dr. Sekhar Mallangi, a Former Nestle SA Chief Scientist and the creator of Type2 Defense™. Ms. Dana Kraft, a well-recognized UK Naturopath. Mr. Gallagher's next mission is to recruit a soon to be Type2 Defense™ celebrity spokesperson, who will be endorsing the T2 Brand.

Bio-Solution Corp is a NV Corp, with Headquarters recently relocated to San Antonio Texas. Operations will be managed in San Antonio. Research and Development is managed by Dr. Mallangi. Product fulfillment will be handled by Lou Bellino, one of America's top web product fulfillment operators, marketing will be driven by the talented San Antonio based marketing firm BOSS Creative for the company's new upcoming website development. Search engine optimization (SEO) management, video product description and newsletters.

"Since the addition of both Type2 Defense™ and me, the company has never been in a better position to move forward. Production is occurring and the first product run of Type2 Defense™ is expected September 2012," stated CEO Bill Gallagher.

Bio-Solutions Corp. (BISU.QB) (BISU.PK)

Shares Outstanding: 67,190,397
Float: 15,000,000
Shares Authorized: 90,000,000